AWM
CC icon

Aevitas Wealth Management’s Chemours CC Stock Holding History

Aevitas Wealth Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-80
Closed -$3K – 400
2018
Q3 		$3K Hold
80
– – ﹤0.01% 409
2018
Q2 		$4K Hold
80
– – ﹤0.01% 373
2018
Q1 		$4K Sell
80
-60
-43% -$3K ﹤0.01% 376
2017
Q4 		$7K Buy
+140
New +$7.33K 0.01% 347

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Aevitas Wealth Management's CC Position: Q4 2018 in Review

Aevitas Wealth Management sold out of Chemours (CC) in Q4 2018, closing a stake of 80 shares — an estimated $3K sold.

Aevitas Wealth Management first reported a position in CC in Q4 2017 and held it in 4 quarters. The position peaked at $7K in Q4 2017. 506 funds tracked by Wall St. Rank hold CC as of Q4 2018.

  • Aevitas Wealth Management reported no remaining Chemours position as of Q4 2018 after selling out during the quarter.
  • Aevitas Wealth Management sold 80 Chemours shares in Q4 2018, an estimated $3K.
  • Aevitas Wealth Management first reported a position in Chemours in Q4 2017 and held it in 4 quarters.
  • Aevitas Wealth Management's Chemours position peaked at $7K in Q4 2017.
  • 506 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on Aevitas Wealth Management's 13F filing for Q4 2018, filed 14 Feb 2019.